SCHEMBL22148706

SCHEMBL22148706

c1ccc(-c2cc(-c3ccccc3-c3c(-n4c5ccccc5c5ccncc54)c(-n4c5ccccc5c5ccncc54)nc(-n4c5ccccc5c5ccncc54)c3-n3c4ccccc4c4ccncc43)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 3/20 0.33
NTSR1 P30989 1/20 0.33
LMNA P02545 4/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPK10 P53779 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALOX5 P09917 1/20 0.32
TNF P01375 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NPSR1 Q6W5P4 2/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22148532 0.94 MAOA (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL22148721 0.94 MAOA (0.35) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL22148530 0.94 TNF (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL22148591 0.91 MEN1 (0.39) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL30709433 0.89 TNF (0.35) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL22148660 0.87 MAOA (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL30709653 0.87 TNF (0.36) MEN1KMT2AALOX5TNFDYRK1A
SCHEMBL22148917 0.87 MAOA (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL30709206 0.87 MAOA (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL22148726 0.86 TOP1 (0.34) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 MAPT 275/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.